Даградуо

Даградуо combines sitagliptin and dapagliflozin for type 2 diabetes management. This oral medication helps regulate blood sugar levels by targeting multiple pathways. Suitable for adults with diabetes seeking improved glycemic control. Available in the EU market.

Даградуо is used to improve blood sugar levels in adults with type 2 diabetes. It combines two active ingredients that work together to support glycemic control. This medication is typically prescribed when diet and exercise alone are not sufficient. It may be used alongside other diabetes treatments as directed by a healthcare provider.

Users may experience improved blood sugar regulation when taking Даградуо as part of their diabetes management plan. The combination of sitagliptin and dapagliflozin helps maintain more stable glucose levels throughout the day. Some individuals notice better energy levels and reduced diabetes-related symptoms over time.

Store Даградуо at room temperature away from moisture and heat. Keep this medication out of reach of children and pets. Always check the expiration date before use and discard any unused medication properly. Consult a healthcare professional if you experience persistent side effects or unusual symptoms.

Alcohol may affect blood sugar levels and increase the risk of side effects when taken with Даградуо. Certain medications, including diuretics and insulin, may interact with this combination treatment. Always inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.